Login / Signup

Interim Phase II Results Using Panitumumab-IRDye800CW During Transoral Robotic Surgery in Patients with Oropharyngeal Cancer.

Logan D StoneBenjamin B KastenShilpa RaoManuel Lora GonzalezTodd M StevensDiana M LinWilliam CarrollBenjamin GreeneLindsay S MooreAndrew FusonSherin JamesYolanda E HartmanSusan D McCammonBharat Akhanda PanugantiLisle M NabellYufeng LiMei LiLuke BaileyEben L RosenthalHarishanker JeyarajanCarissa M ThomasJason M Warram
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Results from this OPSCC patient cohort support further clinical assessment of FGS during TORS to aid resection of solid tumors.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • papillary thyroid
  • case report
  • squamous cell
  • phase iii
  • double blind
  • placebo controlled
  • metastatic colorectal cancer
  • wild type
  • randomized controlled trial
  • lymph node metastasis